RxDoctor Payments Data

Derrick Blackwell, DO

Family Medicine · Charlotte, NCNPI 1134348485

Payments from drug & device makers

$1,256in general payments, 2019–2025

Across 74 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$356
  • Abbott$284
  • Boehringer Ingelheim$159
  • Bayer$100
  • Novo Nordisk$67
  • Johnson & Johnson$60
  • plus $231 from 7 others

What the payments were for

  • Travel & lodging$13411%
  • Food & beverage$1,10888%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,256 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$44,238
Medicare patients
96
Services billed
590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Breo ElliptaFluticasone/Vilanterol12$4,809
SynthroidLevothyroxine Sodium11$1,167
Rosuvastatin Calcium18$499
Atorvastatin Calcium44$405
Fluticasone Propionate11$366
Pantoprazole Sodium12$316
Levothyroxine Sodium15$311
Simvastatin13$310
Amlodipine Besylate24$308
Bupropion XlBupropion Hcl12$223
Gabapentin14$189
Omeprazole19$183
Lisinopril36$166
Clonazepam12$166
Losartan Potassium18$146

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$17$1,16711 claims
PfizerPaxlovid$15$016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →